Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive Article

publication date

  • January 1, 2016

webpage

published in

keywords

  • Ethinyl estradiol
  • Norethindrone acetate
  • Obesity
  • Oral contraceptive
  • Weight

start page

  • 52

end page

  • 57

volume

  • 93

issue

  • 1